JP2021512921A5 - - Google Patents
Info
- Publication number
- JP2021512921A5 JP2021512921A5 JP2020542862A JP2020542862A JP2021512921A5 JP 2021512921 A5 JP2021512921 A5 JP 2021512921A5 JP 2020542862 A JP2020542862 A JP 2020542862A JP 2020542862 A JP2020542862 A JP 2020542862A JP 2021512921 A5 JP2021512921 A5 JP 2021512921A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- administered
- product according
- day
- pharmaceutically acceptable
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629579P | 2018-02-12 | 2018-02-12 | |
| US62/629,579 | 2018-02-12 | ||
| PCT/US2019/017430 WO2019157423A1 (en) | 2018-02-12 | 2019-02-11 | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512921A JP2021512921A (ja) | 2021-05-20 |
| JPWO2019157423A5 JPWO2019157423A5 (https=) | 2022-02-17 |
| JP2021512921A5 true JP2021512921A5 (https=) | 2022-02-17 |
Family
ID=67542181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542862A Pending JP2021512921A (ja) | 2018-02-12 | 2019-02-11 | 癌療法に対するイブジラストおよび第二の薬剤を使用した方法ならびに投与レジメン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10744123B2 (https=) |
| EP (1) | EP3752147A4 (https=) |
| JP (1) | JP2021512921A (https=) |
| CN (1) | CN112236140A (https=) |
| CA (1) | CA3090884A1 (https=) |
| WO (1) | WO2019157423A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019157423A1 (en) * | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
| CA3226898A1 (en) | 2021-07-26 | 2023-02-02 | Kazuko Matsuda | Ibudilast for preventing eye cancer metastasis |
| CN113584172B (zh) * | 2021-08-04 | 2022-08-02 | 中南大学湘雅二医院 | Slc12a5及其抑制剂的应用 |
| US20230090534A1 (en) * | 2021-09-21 | 2023-03-23 | Medicinova, Inc. | Methods of treating glioblastoma multiforme using combination therapy |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1106178T3 (da) | 1998-08-10 | 2005-02-28 | Kyorin Seiyaku Kk | Anvendelse af ibudilast til fremstilling af et lægemiddel til behandling af dissemineret sklerose |
| MX2007006777A (es) | 2004-12-06 | 2007-08-06 | Avigen Inc | Ibudilast para tratar dolor neuropatico y sindromes asociados. |
| TW200716141A (en) * | 2005-05-05 | 2007-05-01 | Combinatorx Inc | Compositions and methods for treatment for neoplasms |
| CA2970273C (en) | 2007-07-11 | 2020-04-14 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| BR112014017833A2 (pt) * | 2012-01-20 | 2021-03-23 | Dennis Brown | Uso de hexitóis substituídos incluindo dianidrogalactitol e análogos para tratar doença neoplástica e células-tronco de câncer incluindo glioblastoma multiforme e meduloblastoma |
| US20160361298A1 (en) * | 2015-06-11 | 2016-12-15 | Globavir Biosciences, Inc. | Methods and compositions for treating cancer |
| EP3558301A4 (en) * | 2016-12-22 | 2020-07-29 | MediciNova, Inc. | METHOD FOR TREATING GLIOBLASTOMA MULTIFORME WITH IBUDILAST |
| WO2019157423A1 (en) * | 2018-02-12 | 2019-08-15 | Medicinova, Inc. | Methods and dosing regimens using ibudilast and a second agent for cancer therapy |
-
2019
- 2019-02-11 WO PCT/US2019/017430 patent/WO2019157423A1/en not_active Ceased
- 2019-02-11 CN CN201980022054.9A patent/CN112236140A/zh active Pending
- 2019-02-11 CA CA3090884A patent/CA3090884A1/en active Pending
- 2019-02-11 US US16/272,694 patent/US10744123B2/en active Active
- 2019-02-11 EP EP19751704.8A patent/EP3752147A4/en not_active Withdrawn
- 2019-02-11 JP JP2020542862A patent/JP2021512921A/ja active Pending
-
2020
- 2020-07-10 US US16/926,441 patent/US11446283B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512921A5 (https=) | ||
| CA2856646C (en) | Combination treatment of cancer | |
| JP2015512406A5 (https=) | ||
| JP2022095882A5 (ja) | 医薬組成物 | |
| JP2018520189A5 (https=) | ||
| TW200916103A (en) | Therapeutic compositions and methods | |
| JPWO2019107530A1 (ja) | 炎症性腸疾患の治療薬 | |
| CA3034875C (en) | Combination therapies for the treatment of hepatocellular carcinoma | |
| JP2009517411A5 (https=) | ||
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| JP2019507786A5 (https=) | ||
| TWI606826B (zh) | 艾拉莫德或其鹽之用途 | |
| CN120713908A (zh) | 帕布昔利布在黏膜恶性黑色素瘤中的应用 | |
| JPWO2019157423A5 (https=) | ||
| JP2021535163A5 (https=) | ||
| CA2986359A1 (en) | Pharmaceutical combination of everolimus with dactolisib | |
| CA2684174C (fr) | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson | |
| AU2007234917B2 (en) | Renin inhibitors for the treatment of hypertension | |
| JPH0359044B2 (https=) | ||
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP7267326B2 (ja) | 成熟脳損傷の治療における使用のためのｍＧｌｕＲ５のネガティブアロステリックモジュレーター | |
| CN114340672B (zh) | 包含hdac抑制剂和抗pd1抗体或抗pd-l1抗体的药物组合物 | |
| EP3411027A1 (en) | Extended release formulations of veliparib for the treatment of cancer | |
| CN112826820B (zh) | Nlrp3抑制剂及其应用 | |
| Kakar et al. | Hypersensitivity to romidepsin |